C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022
WATERTOWN, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced that C4T management will participate in a fireside chat at the virtual Bank of America Securities Precision Oncology Conference 2022.
Related news for (CCCC)
- MoBot’s Stock Market Highlights – 08/18/25 03:00 PM
- MoBot’s Stock Market Highlights – 08/18/25 02:00 PM
- Today’s Top Performers: MoBot’s Market Review 08/07/25 07:00 PM
- MoBot alert highlights: NASDAQ: CLIK, NASDAQ: SKYT, NASDAQ: CCCC, NASDAQ: ABCL, NASDAQ: VREX (08/07/25 06:00 PM)
- MoBot alert highlights: NASDAQ: CLIK, NASDAQ: SKYT, NASDAQ: CCCC, NASDAQ: ABCL, NASDAQ: VREX (08/07/25 05:00 PM)